SPERO THERAPEUTICS, INC. (SPRO) scores 53 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 2.6, representing a 5% premium to fair value. Quantitative score: 47/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.